Voie wnt/β-catènine et zonation métabolique du foie un nouvel acteur pour un ancien concept

Medecine/Sciences

Volumn 22, Issue 11, 2006, Pages 904-906

  Benhamouche, Samira ^a   Decaens, Thomas ^a   Perret, Christine ^a   Colnot, Sabine ^a  

^a INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; WNT PROTEIN;

ARTICLE; BIOLOGICAL MODEL; HISTOLOGY; HUMAN; LIVER; METABOLISM; PHYSIOLOGY;

BETA CATENIN; HUMANS; LIVER; MODELS, BIOLOGICAL; WNT PROTEINS;

EID: 39049178492     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/20062211904     Document Type: Article

References (10)

1. Jungermann K, Sasse D. Heterogeneity of liver parenchymal cells. Trends Biochem Sci 1978; 3: 198-202.
2. Cadoret A, Ovejero C, Terris B, et al. New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene 2002; 21: 8293-301.
3. Colnot S, Decaens T, Niwa-Kawakita M, et a!. Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas. Proc Nat! Acad Sci USA 2004; 101: 17216-21.
4. Ovejero C, Cavard C, Perianin A, et al. Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver. Hepatology 2004; 40: 167-76.
5. Benhamouche S, Decaens T, Godard C, et al. Apc tumor suppressor gene is the «zonation-keeper» of mouse liver. Dev Cell 2006 (sous presse).
6. Hailfinger S, Jaworski M, Braeuning A, et al. M. Zonal gene expression in murine liver: lessons from tumors. Hepato!ogy 2006; 43: 407-14.
7. Sekine S, Lan BY, Bedolli M, et al. Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice. Hepato!ogy 2006; 43: 817-25.
8. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Ce!! 1996; 87: 159-70.
9. De La Coste A, Romagnolo B, Billuart P, et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Nat! Acad Sci USA 1998; 95: 8847-51.
10. Colnot S, Decaens T, Perret C. Activating a beta-catenin signal in the liver is oncogenic. Med Sci (Paris) 2005; 21: 355-7.